Literature DB >> 21109378

Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production.

Yoshiki Asayama1, Tsuyoshi Tajima, Akihiro Nishie, Kousei Ishigami, Daisuke Kakihara, Tomohiro Nakayama, Daisuke Okamoto, Nobuhiro Fujita, Shinichi Aishima, Ken Shirabe, Hiroshi Honda.   

Abstract

PURPOSE: The aim of this study was to reveal the relationship between intratumoral uptake of gadoliniumethoxylbenzyldiethylenetriaminepentaacetic acid (Gd-EOB-DTPA) of hepatocellular carcinoma (HCC) in the hepatobiliary phase and pathological features.
MATERIALS AND METHODS: Sixty HCC nodules were confirmed at pathology in 56 patients who had undergone dynamic MRI. T1-weighted 3D gradient echo sequences before and 20 min (hepatobiliary phase) after the injection of Gd-EOB-DTPA were performed. Uptake of Gd-EOB-DTPA was defined as an increase in signal intensity in the hepatobiliary phase compared with the precontrast scan. All surgical specimens were fixed with formalin and then digitally photographed. The relationship between Gd-EOB-DTPA uptake and histological findings, including a macroscopic greenish area, was examined.
RESULTS: MR images showed uptake of Gd-EOB-DTPA in twenty-two nodules. Histological findings indicated twenty-six nodules contained a greenish area. There is a significant correlation between HCC showing Gd-EOB-DTPA uptake and the presence of a greenish area (p<0.001). On a nodule-by-nodule basis, more than two-thirds of the area of Gd-EOB DTPA uptake coincides with the greenish part in only 12 of 22 lesions (54.5%). More than two-thirds of the greenish area coincided with that of Gd-EOB-DTPA uptake in only 10 of 26 cases (38.5%).
CONCLUSION: The area of Gd-EOB-DTPA uptake does not always match the greenish part, but HCC with uptake of Gd-EOB-DTPA significantly correlated with green HCC.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21109378     DOI: 10.1016/j.ejrad.2010.10.032

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  15 in total

Review 1.  Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review.

Authors:  Paola Erra; Marta Puglia; Alfonso Ragozzino; Simone Maurea; Raffaele Liuzzi; Giuseppe Sabino; Luigi Barbuto; Alberto Cuocolo; Massimo Imbriaco
Journal:  Radiol Med       Date:  2015-04-22       Impact factor: 3.469

2.  Hepatocellular carcinoma: clinical significance of signal heterogeneity in the hepatobiliary phase of gadoxetic acid-enhanced MR imaging.

Authors:  Nobuhiro Fujita; Akihiro Nishie; Yuichiro Kubo; Yoshiki Asayama; Yasuhiro Ushijima; Yukihisa Takayama; Koichiro Moirta; Ken Shirabe; Shinichi Aishima; Hiroshi Honda
Journal:  Eur Radiol       Date:  2014-07-26       Impact factor: 5.315

3.  Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Yukihisa Takayama; Nobuhiro Fujita; Yuichiro Kubo; Shinichi Aishima; Ken Shirabe; Takashi Yoshiura; Hiroshi Honda
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

4.  The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging.

Authors:  Azusa Kitao; Osamu Matsui; Norihide Yoneda; Kazuto Kozaka; Rieko Shinmura; Wataru Koda; Satoshi Kobayashi; Toshifumi Gabata; Yoh Zen; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Eur Radiol       Date:  2011-05-29       Impact factor: 5.315

5.  Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images.

Authors:  Azusa Kitao; Osamu Matsui; Norihide Yoneda; Kazuto Kozaka; Satoshi Kobayashi; Wataru Koda; Toshifumi Gabata; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma; Ryuichi Kita; Shigeki Arii
Journal:  Radiology       Date:  2012-12       Impact factor: 11.105

Review 6.  Role of stereotactic body radiation therapy for hepatocellular carcinoma.

Authors:  Naoko Sanuki; Atsuya Takeda; Etsuo Kunieda
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

Review 7.  MRI features of hepatocellular carcinoma related to biologic behavior.

Authors:  Eun-Suk Cho; Jin-Young Choi
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

Review 8.  Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma.

Authors:  Xue-Qin Li; Xing Wang; Da-Wei Zhao; Jun Sun; Jiao-Jiao Liu; Dong-Dong Lin; Guang Yang; Hui Liu; Zhen-Ying Xia; Cui-Yu Jia; Hong-Jun Li
Journal:  World J Surg Oncol       Date:  2020-08-22       Impact factor: 2.754

9.  Application of dual-source CT perfusion imaging and MRI for the diagnosis of primary liver cancer.

Authors:  Dongwen Zhang; Aixia Xu
Journal:  Oncol Lett       Date:  2017-05-15       Impact factor: 2.967

Review 10.  MR with Gd-EOB-DTPA in assessment of liver nodules in cirrhotic patients.

Authors:  Riccardo Inchingolo; Riccardo Faletti; Luigi Grazioli; Eleonora Tricarico; Marco Gatti; Anna Pecorelli; Davide Ippolito
Journal:  World J Hepatol       Date:  2018-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.